Showing results (1911-1920 of 3,476) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|March 12, 2013
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal functionJanna K Duong, Shaun S Kumar, Carl M Kirkpatrick, et al.
Clinical Pharmacokinetics|December 1, 2012
Benchmarking therapeutic drug monitoring software: a review of available computer toolsAline Fuchs, Chantal Csajka, Yann Thoma, et al.
Clinical Pharmacokinetics|November 27, 2012
Population pharmacokinetic analysis during the first 2 years of life: an overviewAmélie Marsot, Audrey Boulamery, Bernard Bruguerolle, et al.
Clinical Pharmacokinetics|April 5, 2013
Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactionsTony K L Kiang, Kyle J Wilby, Mary H H Ensom
Clinical Pharmacokinetics|May 31, 2013
Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptidesLei Diao, Bernd Meibohm
Clinical Pharmacokinetics|May 31, 2013
Pharmacokinetics of oral recombinant human parathyroid hormone [rhPTH(1-31)NH₂] in postmenopausal women with osteoporosisAmy Sturmer, Nozer Mehta, Jenna Giacchi, et al.
Clinical Pharmacokinetics|June 12, 2013
Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D₂-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D₂-receptor occupancyEef Hoeben, Martine Neyens, Erik Mannaert, et al.
Clinical Pharmacokinetics|May 2, 2013
Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipientsKen Ogasawara, Shripad D Chitnis, Reginald Y Gohh, et al.
Clinical Pharmacokinetics|March 27, 2013
Pharmacometric characterization of dabigatran hemodialysisKarl-Heinz Liesenfeld, Alexander Staab, Sebastian Härtter, et al.
Clinical Pharmacokinetics|May 4, 2012
Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibodyAbhijit Chakraborty, Stacey Tannenbaum, Christiane Rordorf, et al.
Pageof 348